AllianceBernstein’s CureVac CVAC Stock Holding History

AllianceBernstein’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-19,304	Closed	-$104K	–	3251
2025 Q3	$104K	Sell	19,304 -387	-2%	-$2.09K	﹤0.01%	3174
2025 Q2	$107K	Hold	19,691	–	–	﹤0.01%	3165
2025 Q1	$54.5K	Hold	19,691	–	–	﹤0.01%	3127
2024 Q4	$67.1K	Hold	19,691	–	–	﹤0.01%	3167
2024 Q3	$57.9K	Hold	19,691	–	–	﹤0.01%	3180
2024 Q2	$66.9K	Hold	19,691	–	–	﹤0.01%	3165
2024 Q1	$59.7K	Hold	19,691	–	–	﹤0.01%	3073
2023 Q4	$82.9K	Hold	19,691	–	–	﹤0.01%	3084
2023 Q3	$134K	Buy	+19,691	New	+$174K	﹤0.01%	3024
2022 Q2	–	Sell	-26,668	Closed	-$523K	–	3290
2022 Q1	$523K	Sell	26,668 -418	-2%	-$8.35K	﹤0.01%	2659
2021 Q4	$929K	Buy	27,086 +6,066	+29%	+$244K	﹤0.01%	2496
2021 Q3	$1.15M	Sell	21,020 -6,690	-24%	-$403K	﹤0.01%	2441
2021 Q2	$2.04M	Buy	+27,710	New	+$2.77M	﹤0.01%	2181

Other funds holding CVAC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

AllianceBernstein's CVAC Position: Q4 2025 in Review

AllianceBernstein sold out of CureVac (CVAC) in Q4 2025, closing a stake of 19,304 shares — an estimated $104K sold.

AllianceBernstein first reported a position in CVAC in Q2 2021 and held it in 13 quarters. The position peaked at $2.04M in Q2 2021. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

AllianceBernstein reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
AllianceBernstein sold 19,304 CureVac shares in Q4 2025, an estimated $104K.
AllianceBernstein first reported a position in CureVac in Q2 2021 and held it in 13 quarters.
AllianceBernstein's CureVac position peaked at $2.04M in Q2 2021.
57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on AllianceBernstein's 13F filing for Q4 2025, filed 17 Feb 2026.